600.07 Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors: A Global Propensity-Matched Analysis
JACC: Cardiovascular Interventions · 2026-03 · 19 (5) · S57
DOI: 10.1016/j.jcin.2026.01.197 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2026-03. Verfasst von Ibrahim Halil Inanc und 5 weiteren Autor:innen.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Inanc, I. H., Chaudhry, A., Inanc, F. A., Aksu, C., Jan, A., & Cilingiroglu, M. (2026). 600.07 Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors: A Global Propensity-Matched Analysis. JACC: Cardiovascular Interventions, 19(5), S57. https://doi.org/10.1016/j.jcin.2026.01.197
Vancouver
Inanc IH, Chaudhry A, Inanc FA, Aksu C, Jan A, Cilingiroglu M. 600.07 Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors: A Global Propensity-Matched Analysis. JACC: Cardiovascular Interventions. 2026;19(5):S57. doi:10.1016/j.jcin.2026.01.197
BibTeX
@article{Inanc2026,
author = {Inanc, Ibrahim Halil and Chaudhry, Afnan and Inanc, Fulden Akyuz and Aksu, Cagri and Jan, Arif and Cilingiroglu, Mehmet},
title = {600.07 Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors: A Global Propensity-Matched Analysis},
journal = {JACC: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {5},
pages = {S57},
doi = {10.1016/j.jcin.2026.01.197}
}
EUVIMED